220 related articles for article (PubMed ID: 24228186)
1. Decreased copper in Alzheimer's disease brain is predominantly in the soluble extractable fraction.
Rembach A; Hare DJ; Lind M; Fowler CJ; Cherny RA; McLean C; Bush AI; Masters CL; Roberts BR
Int J Alzheimers Dis; 2013; 2013():623241. PubMed ID: 24228186
[TBL] [Abstract][Full Text] [Related]
2. Copper Toxicity Links to Pathogenesis of Alzheimer's Disease and Therapeutics Approaches.
Ejaz HW; Wang W; Lang M
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33081348
[TBL] [Abstract][Full Text] [Related]
3. Copper Imbalance in Alzheimer's Disease: Meta-Analysis of Serum, Plasma, and Brain Specimens, and Replication Study Evaluating
Squitti R; Ventriglia M; Simonelli I; Bonvicini C; Costa A; Perini G; Binetti G; Benussi L; Ghidoni R; Koch G; Borroni B; Albanese A; Sensi SL; Rongioletti M
Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34209820
[TBL] [Abstract][Full Text] [Related]
4. Patients with Increased Non-Ceruloplasmin Copper Appear a Distinct Sub-Group of Alzheimer's Disease: A Neuroimaging Study.
Squitti R; Simonelli I; Cassetta E; Lupoi D; Rongioletti M; Ventriglia M; Siotto M
Curr Alzheimer Res; 2017; 14(12):1318-1326. PubMed ID: 28669331
[TBL] [Abstract][Full Text] [Related]
5. Trace element alterations in Alzheimer's disease: A review.
Cilliers K
Clin Anat; 2021 Jul; 34(5):766-773. PubMed ID: 33580904
[TBL] [Abstract][Full Text] [Related]
6. Sex-dependent effect of sublethal copper concentrations on de novo cholesterol synthesis in astrocytes and their possible links to variations in cholesterol and amyloid precursor protein levels in neuronal membranes.
Zubillaga M; Tau J; Rosa D; Bellini MJ; Arnal N
Biol Sex Differ; 2024 Jan; 15(1):4. PubMed ID: 38191520
[TBL] [Abstract][Full Text] [Related]
7. Copper dyshomeostasis in Wilson disease and Alzheimer's disease as shown by serum and urine copper indicators.
Squitti R; Ghidoni R; Simonelli I; Ivanova ID; Colabufo NA; Zuin M; Benussi L; Binetti G; Cassetta E; Rongioletti M; Siotto M
J Trace Elem Med Biol; 2018 Jan; 45():181-188. PubMed ID: 29173477
[TBL] [Abstract][Full Text] [Related]
8. Plasma metals as potential biomarkers in dementia: a case-control study in patients with sporadic Alzheimer's disease.
Xu J; Church SJ; Patassini S; Begley P; Kellett KAB; Vardy ERLC; Unwin RD; Hooper NM; Cooper GJS
Biometals; 2018 Apr; 31(2):267-276. PubMed ID: 29516299
[TBL] [Abstract][Full Text] [Related]
9. Non-Ceruloplasmin Copper Identifies a Subtype of Alzheimer's Disease (CuAD): Characterization of the Cognitive Profile and Case of a CuAD Patient Carrying an
Squitti R; Catalli C; Gigante L; Marianetti M; Rosari M; Mariani S; Bucossi S; Mastromoro G; Ventriglia M; Simonelli I; Tondolo V; Singh P; Kumar A; Pal A; Rongioletti M
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047347
[TBL] [Abstract][Full Text] [Related]
10. The distribution profile and oxidation states of biometals in APP transgenic mouse brain: dyshomeostasis with age and as a function of the development of Alzheimer's disease.
Wang H; Wang M; Wang B; Li M; Chen H; Yu X; Zhao Y; Feng W; Chai Z
Metallomics; 2012 Mar; 4(3):289-96. PubMed ID: 22301945
[TBL] [Abstract][Full Text] [Related]
11. Role of Copper in the Onset of Alzheimer's Disease Compared to Other Metals.
Bagheri S; Squitti R; Haertlé T; Siotto M; Saboury AA
Front Aging Neurosci; 2017; 9():446. PubMed ID: 29472855
[TBL] [Abstract][Full Text] [Related]
12. Copper Imbalance in Alzheimer's Disease and Its Link with the Amyloid Hypothesis: Towards a Combined Clinical, Chemical, and Genetic Etiology.
Squitti R; Faller P; Hureau C; Granzotto A; White AR; Kepp KP
J Alzheimers Dis; 2021; 83(1):23-41. PubMed ID: 34219710
[TBL] [Abstract][Full Text] [Related]
13. Homocysteine potentiates copper- and amyloid beta peptide-mediated toxicity in primary neuronal cultures: possible risk factors in the Alzheimer's-type neurodegenerative pathways.
White AR; Huang X; Jobling MF; Barrow CJ; Beyreuther K; Masters CL; Bush AI; Cappai R
J Neurochem; 2001 Mar; 76(5):1509-20. PubMed ID: 11238735
[TBL] [Abstract][Full Text] [Related]
14. Metal and complementary molecular bioimaging in Alzheimer's disease.
Braidy N; Poljak A; Marjo C; Rutlidge H; Rich A; Jayasena T; Inestrosa NC; Sachdev P
Front Aging Neurosci; 2014; 6():138. PubMed ID: 25076902
[TBL] [Abstract][Full Text] [Related]
15. Challenges and Opportunities of Metal Chelation Therapy in Trace Metals Overload-Induced Alzheimer's Disease.
Chaudhari V; Bagwe-Parab S; Buttar HS; Gupta S; Vora A; Kaur G
Neurotox Res; 2023 Jun; 41(3):270-287. PubMed ID: 36705861
[TBL] [Abstract][Full Text] [Related]
16. Alzheimer's Drug PBT2 Interacts with the Amyloid β 1-42 Peptide Differently than Other 8-Hydroxyquinoline Chelating Drugs.
Summers KL; Roseman G; Schilling KM; Dolgova NV; Pushie MJ; Sokaras D; Kroll T; Harris HH; Millhauser GL; Pickering IJ; George GN
Inorg Chem; 2022 Sep; 61(37):14626-14640. PubMed ID: 36073854
[TBL] [Abstract][Full Text] [Related]
17. Copper and Alzheimer's Disease.
Mathys ZK; White AR
Adv Neurobiol; 2017; 18():199-216. PubMed ID: 28889269
[TBL] [Abstract][Full Text] [Related]
18. Evidence for widespread, severe brain copper deficiency in Alzheimer's dementia.
Xu J; Church SJ; Patassini S; Begley P; Waldvogel HJ; Curtis MA; Faull RLM; Unwin RD; Cooper GJS
Metallomics; 2017 Aug; 9(8):1106-1119. PubMed ID: 28654115
[TBL] [Abstract][Full Text] [Related]
19. Is There a Connection between the Metabolism of Copper, Sulfur, and Molybdenum in Alzheimer's Disease? New Insights on Disease Etiology.
Coelho FC; Cerchiaro G; Araújo SES; Daher JPL; Cardoso SA; Coelho GF; Guimarães AG
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887282
[TBL] [Abstract][Full Text] [Related]
20. Acetylcholinesterase inhibitors in Alzheimer's disease influence Zinc and Copper homeostasis.
Giacconi R; Giuli C; Casoli T; Balietti M; Costarelli L; Provinciali M; Basso A; Piacenza F; Postacchini D; Galeazzi R; Fattoretti P; Nisi L; Fabbietti P; Papa R; Malavolta M
J Trace Elem Med Biol; 2019 Sep; 55():58-63. PubMed ID: 31345366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
